Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shusuke Numata

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
BMC Psychiatry|May 28, 2024
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter studyToshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
Sleep Medicine|December 7, 2021
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide studyRyuji Furihata, Rei Otsuki, Naomi Hasegawa, et al.
Schizophrenia Research|January 7, 2010
The chitinase 3-like 1 gene and schizophrenia: evidence from a multi-center case-control study and meta-analysisKazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, et al.
BMC Psychiatry|June 28, 2023
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment projectNaoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|November 2, 2023
Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control studyTzuyao Lo, Itaru Kushima, Hiroki Kimura, et al.
Schizophrenia Research|February 25, 2009
Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter studyKazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, et al.
Biological Psychiatry|February 16, 2016
Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese PopulationTakeo Saito, Masashi Ikeda, Taisei Mushiroda, et al.
The International Journal of Neuropsychopharmacology|June 20, 2022
Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide StudyShinichiro Ochi, Hiromi Tagata, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|November 29, 2022
Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" projectHitoshi Iida, Tsuyoshi Okada, Kiyotaka Nemoto, et al.
Journal of Clinical Psychopharmacology|May 22, 2023
Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in JapanToshiaki Onitsuka, Tsuyoshi Okada, Naomi Hasegawa, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
BMC Psychiatry|May 28, 2024
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter studyToshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
Sleep Medicine|December 7, 2021
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide studyRyuji Furihata, Rei Otsuki, Naomi Hasegawa, et al.
Schizophrenia Research|January 7, 2010
The chitinase 3-like 1 gene and schizophrenia: evidence from a multi-center case-control study and meta-analysisKazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, et al.
BMC Psychiatry|June 28, 2023
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment projectNaoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|November 2, 2023
Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control studyTzuyao Lo, Itaru Kushima, Hiroki Kimura, et al.
Schizophrenia Research|February 25, 2009
Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter studyKazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, et al.
Biological Psychiatry|February 16, 2016
Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese PopulationTakeo Saito, Masashi Ikeda, Taisei Mushiroda, et al.
The International Journal of Neuropsychopharmacology|June 20, 2022
Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide StudyShinichiro Ochi, Hiromi Tagata, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|November 29, 2022
Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" projectHitoshi Iida, Tsuyoshi Okada, Kiyotaka Nemoto, et al.
Journal of Clinical Psychopharmacology|May 22, 2023
Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in JapanToshiaki Onitsuka, Tsuyoshi Okada, Naomi Hasegawa, et al.
Pageof 15